Oruka Therapeutics, Inc. (ORKA) Insider Trading

Name: Oruka Therapeutics, Inc. (ORKA) insider trading: SEC Form 4 filings
Creator: Insiders Notifier
License: https://www.sec.gov/privacy#dissemination

Latest Form 4 (Oct 2, 2026): Lawrence Otto Klein (Chief Executive Officer): Exercise/Conversion of 25,000 shares, $195.0K.

Get alerted when insiders trade ORKA

Every alert includes an AI-written analysis of the filing, plus news and market context.

Email address

Loading company data...

Beta

Loading company details...

Beta